MK Proteins Intrinsic Value
MKPL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.40 | ₹1.92 - ₹2.88 | -59.8% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹14.92 | ₹13.43 - ₹16.41 | +149.9% | Book Value/Share: ₹18.42, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹11.94 | ₹10.75 - ₹13.13 | +100.0% | Revenue/Share: ₹85.26, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹11.94 | ₹10.75 - ₹13.13 | +100.0% | EBITDA: ₹13.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹14.92 | ₹11.94 - ₹17.90 | +149.9% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.79 | ₹1.61 - ₹1.97 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.79 | ₹1.61 - ₹1.97 | -70.0% | Revenue Growth: 6.1%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹11.94 | ₹10.75 - ₹13.13 | +100.0% | ROE: 12.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹9.10 | ₹8.19 - ₹10.01 | +52.4% | EPS: ₹0.20, BVPS: ₹18.42 |
Want to compare with current market value? Check MKPL share price latest .
Valuation Comparison Chart
MKPL Intrinsic Value Analysis
What is the intrinsic value of MKPL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of MK Proteins (MKPL) is ₹11.94 (median value). With the current market price of ₹5.97, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.79 to ₹14.92, indicating ₹1.79 - ₹14.92.
Is MKPL undervalued or overvalued?
Based on our multi-method analysis, MK Proteins (MKPL) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 59.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.87 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 12.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.47x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for MK Proteins
Additional stock information and data for MKPL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹32 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-10 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |